Shares in U.S. drug maker Moderna soar after possible COVID-19 vaccine deemed ready for testing
Shares in U.S. drug company Moderna Inc. surge by more than 16 per cent after the company announced it has shipped its first batch of a possible coronavirus vaccine for humans to the government department in charge of testing its safety and effectiveness.
Source: CBC